On December 21, 2020, NCHC sent a letter to President-Elect Biden’s transition team applauding the campaign’s focus on health care and the coronavirus (COVID-19) pandemic, and further urging the incoming administration to consider addressing health care affordability as a top priority in 2021. Read the full letter here.
The National Coalition on Health Care held a virtual conference with health care leaders on October 1, 2020. The impact of COVID-19 on communities of color was a major theme of the conversation. To date, the US has had over 275,000 COVID-19 deaths and over 14 million cases – numbers that are rising every day. […]
On July 24, President Trumped signed a series of executive order (EOs) focused on reducing Medicare beneficiary and program spending on prescription drugs. One executive order, the details of which were not immediately released, would set prices for drugs in Medicare Part B to no more than the prices paid by a basket of other […]
As drug prices continue to rise, policymakers debate drug pricing reform. The United States spends more on prescription drugs per capita than any other developed country. For example, Germany spends an average of $685 on retail prescription drugs per capita, while the United States spends over $1,000. Yet, Germany has a similar health care system […]
Yesterday, negotiations over a fourth major COVID-19 relief package began in earnest after the Senate released the Health, Economic Assistance, Liability Protection and Schools (HEALS) Act. The National Coalition on Health Care (NCHC) applauds some elements of the bill, including critical funding for schools and nursing homes, which is necessary for both our economic recovery […]